These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Multiple myeloma. II. The value of melphalan. Bernard DB, Lynch SR, Bothwell TH, Bezwoda WR, Stevens K, Shulman G. S Afr Med J; 1974 May 18; 48(24):1026-8. PubMed ID: 4835772 [No Abstract] [Full Text] [Related]
3. Treatment of plasma cell myeloma with cytotoxic agents. Bergsagel DE, Pruzanski W. Arch Intern Med; 1975 Jan 18; 135(1):172-6. PubMed ID: 803363 [Abstract] [Full Text] [Related]
4. Bence Jones proteins and light chains of immunoglobulins. XI. A transient Bence Jones-related protein associated with corticosteroid therapy. Solomon A, McLaughlin CL, Capra JD. J Clin Invest; 1975 Mar 18; 55(3):579-86. PubMed ID: 803979 [Abstract] [Full Text] [Related]
12. The laboratory diagnosis of plasma cell myeloma and related disorders. Nawab RA, Azar HA. Orthop Clin North Am; 1979 Apr 20; 10(2):391-404. PubMed ID: 109804 [Abstract] [Full Text] [Related]
17. Multiple myeloma. I. Clinical, biochemical and immunochemical aspects. Shulman G, Stevens K, Bernard DB, Bothwell TH, Bezwoda WR, Lynch SR. S Afr Med J; 1974 May 18; 48(24):1023-6. PubMed ID: 4209148 [No Abstract] [Full Text] [Related]
18. The effect of 1-phenylalanine mustard on anti-globulin antibodies in multiple myeloma. Waller M, Moon JH, Irby R, Toone EC. Clin Exp Immunol; 1971 Jan 18; 8(1):91-100. PubMed ID: 4993198 [Abstract] [Full Text] [Related]
19. Correlation of abnormal immunoglobulin with clinical features of myeloma. Arch Intern Med; 1975 Jan 18; 135(1):46-52. PubMed ID: 1111470 [Abstract] [Full Text] [Related]